BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34888236)

  • 41. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
    Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
    Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
    Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
    Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
    Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
    Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
    Condoluci A; Rossi D; Zucca E; Cavalli F
    Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.
    Chen D; Ketterling RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS
    Am J Surg Pathol; 2011 Jul; 35(7):1080-4. PubMed ID: 21677543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.
    Hernández L; Hernández S; Beà S; Pinyol M; Ferrer A; Bosch F; Nadal A; Fernández PL; Palacín A; Montserrat E; Campo E
    Leukemia; 1999 Dec; 13(12):2087-93. PubMed ID: 10602433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas.
    Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Plendl H; Metzke S; Joos S; Zucca E; Weber-Matthiesen K; Roggero E; Grote W; Schlegelberger B
    Ann Oncol; 1998 May; 9(5):519-26. PubMed ID: 9653493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.
    Schmitz R; Renné C; Rosenquist R; Tinguely M; Distler V; Menestrina F; Lestani M; Stankovic T; Austen B; Bräuninger A; Hansmann ML; Küppers R
    Leukemia; 2005 Aug; 19(8):1452-8. PubMed ID: 15973455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.
    Sander B
    Semin Diagn Pathol; 2011 Aug; 28(3):245-55. PubMed ID: 21850989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Follicular and mantle cell lymphoma diagnosed in biopsies of gastroenterocolic region].
    Plank L; Balhárek T; Szépe P
    Cesk Patol; 2016; 52(1):31-9. PubMed ID: 27108554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic features of 112 cases with mantle cell lymphoma.
    Zhou DM; Chen G; Zheng XW; Zhu WF; Chen BZ
    Cancer Biol Med; 2015 Mar; 12(1):46-52. PubMed ID: 25859411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
    Vater I; Wagner F; Kreuz M; Berger H; Martín-Subero JI; Pott C; Martinez-Climent JA; Klapper W; Krause K; Dyer MJ; Gesk S; Harder L; Zamo A; Dreyling M; Hasenclever D; Arnold N; Siebert R
    Br J Haematol; 2009 Feb; 144(3):317-31. PubMed ID: 19016712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
    Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
    Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ill-fitting dentures as primary presentation of mantle cell lymphoma: A case report and literature review of the primary mantle cell lymphomas of the hard palate.
    Dereci Ö; Ay S; Açıkalın MF; Karagülle M
    J Oral Maxillofac Pathol; 2015; 19(2):255-9. PubMed ID: 26604506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
    Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
    Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.
    Gallo M; Cacheux V; Vincent L; Bret C; Tempier A; Guittard C; Macé A; Leventoux N; Costes V; Szablewski V
    Virchows Arch; 2016 Dec; 469(6):697-706. PubMed ID: 27605053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.